Carregant...
ADVANCING THE MRD CONCEPT IN ACUTE MYELOID LEUKEMIA
The criteria to evaluate response to treatment in acute myeloid leukemia (AML) have changed little in the past sixty years. It is now possible to use higher sensitivity tools to measure residual disease burden in AML. Such minimal or measurable residual disease (MRD) measurements provide a deeper un...
Guardat en:
| Publicat a: | Semin Hematol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484880/ https://ncbi.nlm.nih.gov/pubmed/26111465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2015.04.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|